Barak F - Search Results

1

The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.

Kreiss Y, Barak F, Baruch RG, Levy-Lahad E, Pras E, Friedman E. Kreiss Y, et al. Among authors: barak f. Genet Test. 2000;4(4):403-7. doi: 10.1089/109065700750065171. Genet Test. 2000. PMID: 11216667

2

Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.

Schayek H, Laitman Y, Katz LH, Pras E, Ries-Levavi L, Barak F, Friedman E. Schayek H, et al. Among authors: barak f. Isr Med Assoc J. 2017 Jun;19(6):365-367. Isr Med Assoc J. 2017. PMID: 28647934 Free article.

3

Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

Distelman-Menachem T, Shapira T, Laitman Y, Kaufman B, Barak F, Tavtigian S, Friedman E. Distelman-Menachem T, et al. Among authors: barak f. Fam Cancer. 2009;8(2):127-33. doi: 10.1007/s10689-008-9216-6. Epub 2008 Sep 17. Fam Cancer. 2009. PMID: 18798010

4

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.

Barak F, Milgrom R, Laitman Y, Gemer O, Rabinovich A, Piura B, Anteby E, Baruch GB, Korach J, Friedman E. Barak F, et al. Gynecol Oncol. 2010 Dec;119(3):511-5. doi: 10.1016/j.ygyno.2010.08.027. Epub 2010 Sep 17. Gynecol Oncol. 2010. PMID: 20850175

5

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.

Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E. Hassin-Baer S, et al. Among authors: barak f. J Neurol. 2009 Mar;256(3):483-7. doi: 10.1007/s00415-009-0117-x. Epub 2009 Mar 24. J Neurol. 2009. PMID: 19412725

6

MC1R variant alleles and malignant melanoma risk in Israel.

Galore-Haskel G, Azizi E, Mohamdi H, Scope A, Chaudru V, Laitman Y, Barak F, Pavlotsky F, Demenais F, Friedman E. Galore-Haskel G, et al. Among authors: barak f. Eur J Cancer. 2009 Jul;45(11):2015-22. doi: 10.1016/j.ejca.2009.02.001. Epub 2009 Mar 5. Eur J Cancer. 2009. PMID: 19269164

7

Adrenal tumors in BRCA1/BRCA2 mutation carriers.

Barak F, Shiri-Svredlov R, Bruchim-Bar Sade R, Kruglikova A, Friedman E, Ben-Dor D, Goldberg I. Barak F, et al. Am J Med Genet. 2001 Jan 22;98(3):277-9. doi: 10.1002/1096-8628(20010122)98:3<277::aid-ajmg1082>3.0.co;2-q. Am J Med Genet. 2001. PMID: 11169568 No abstract available.

8

BRCA germline mutations in women with uterine serous carcinoma--still a debate.

Lavie O, Ben-Arie A, Segev Y, Faro J, Barak F, Haya N, Auslender R, Gemer O. Lavie O, et al. Among authors: barak f. Int J Gynecol Cancer. 2010 Dec;20(9):1531-4. doi: 10.1111/IGC.0b013e3181cd242f. Int J Gynecol Cancer. 2010. PMID: 21119368

9

Where to die? That is the question: A study of cancer patients in Israel.

Barak F, Livshits S, Kaufer H, Netanel R, Siegelmann-Danieli N, Alkalay Y, Kreitler S. Barak F, et al. Palliat Support Care. 2015 Apr;13(2):165-70. doi: 10.1017/S1478951513000904. Epub 2014 Feb 13. Palliat Support Care. 2015. PMID: 24524381

10

The influence of early diagnosis of endometrioid endometrial cancer on disease stage and survival.

Barak F, Kalichman L, Gdalevich M, Milgrom R, Laitman Y, Piura B, Lavie O, Gemer O. Barak F, et al. Arch Gynecol Obstet. 2013 Dec;288(6):1361-4. doi: 10.1007/s00404-013-2898-5. Epub 2013 May 22. Arch Gynecol Obstet. 2013. PMID: 23695509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters